» Articles » PMID: 25346918

Earlier Re-evaluation May Be Possible in Pediatric Patients with Eutopic Congenital Hypothyroidism Requiring Lower L-thyroxine Doses

Overview
Specialty Pediatrics
Date 2014 Oct 28
PMID 25346918
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The incidence of congenital hypothyroidism (CH) has increased in several countries. Lower cut-off in screening programs have led to an increase in the proportion of transient hypothyroidism (TH) cases diagnosed, leading to debate on the associated clinical and economic impact. This study aimed to identify factors that would allow discrimination between TH and permanent CH (PH) in patients with a eutopic thyroid gland.

Methods: Sixty-six patients with CH from 3 different hospitals were studied: 26 cases of TH, and 40 cases of PH. Laboratory findings and clinical parameters were analysed in 56 patients with eutopic thyroid gland.

Results: Initial serum thyroid stimulating hormone levels and L-thyroxine dose at 12 and 24 months of age were significantly higher in PH than TH patients with a eutopic thyroid gland. The area under the curve for the 12-month and 24-month dose for the prediction of TH in eutopic CH was 0.799 (95% confidence interval [CI], 0.678-0.919; P<0.001) and 0.925 (95% CI, 0.837-1.000; P<0.001), respectively. The optimum 12-month and 24-month dose in predicting TH is 3.25 µg/kg (12-month: sensitivity, 87.1%; specificity, 68.0%; 24-month: sensitivity 93.5%, specificity 88%).

Conclusion: Infants with CH requiring lower L-thyroxine doses (<3.25 µg/kg) are likely to have TH, and thus might be re-evaluated at 12 months or 24 months rather than 3 years of age.

Citing Articles

The natural course of newborns with transient congenital hypothyroidism.

Almagor T, Almashanu S, Elias-Assad G, Admoni O, Ludar H, London S Endocr Connect. 2024; 13(12).

PMID: 39413214 PMC: 11623249. DOI: 10.1530/EC-24-0316.


High frequency of transient congenital hypothyroidism among infants referred for suspected congenital hypothyroidism from the Turkish National screening program: thyroxine dose may guide the prediction of transients.

Ozer Y, Anik A, Sayili U, Tercan U, Deveci Sevim R, Gunes S J Endocrinol Invest. 2024; 47(9):2213-2224.

PMID: 38546931 PMC: 11369008. DOI: 10.1007/s40618-024-02348-9.


Comparison between transient and permanent congenital hypothyroidism on a thyroid function test after re-evaluation.

Lee S, Lee H, Yang E, Kim C Ann Pediatr Endocrinol Metab. 2024; 28(4):245-250.

PMID: 38173380 PMC: 10765033. DOI: 10.6065/apem.2244260.130.


Etiological Profile, Targeted Levothyroxine Dosing and Impact of Partial Newborn Screening in Congenital Hypothyroidism-A Single Centre Experience.

Nagendra L, Bhavani N, Pavithran P, Shenoy M, Menon U, Abraham N Indian J Endocrinol Metab. 2023; 27(5):445-449.

PMID: 38107726 PMC: 10723602. DOI: 10.4103/ijem.ijem_314_22.


Knowns and unknowns about congenital hypothyroidism: 2022 update.

Itonaga T, Hasegawa Y, Higuchi S, Satoh M, Sawada H, Shimura K Clin Pediatr Endocrinol. 2023; 32(1):11-25.

PMID: 36761498 PMC: 9887299. DOI: 10.1297/cpe.2022-0016.


References
1.
Srinivasan R, Harigopal S, Turner S, Cheetham T . Permanent and transient congenital hypothyroidism in preterm infants. Acta Paediatr. 2011; 101(4):e179-82. DOI: 10.1111/j.1651-2227.2011.02536.x. View

2.
Skordis N, Toumba M, Savva S, Erakleous E, Topouzi M, Vogazianos M . High prevalence of congenital hypothyroidism in the Greek Cypriot population: results of the neonatal screening program 1990-2000. J Pediatr Endocrinol Metab. 2005; 18(5):453-61. DOI: 10.1515/jpem.2005.18.5.453. View

3.
Chee Y, Wong K, Low L . Review of primary hypothyroidism in very low birthweight infants in a perinatal centre in Hong Kong. J Paediatr Child Health. 2011; 47(11):824-31. DOI: 10.1111/j.1440-1754.2011.02033.x. View

4.
Horn S, Heuer H . Thyroid hormone action during brain development: more questions than answers. Mol Cell Endocrinol. 2009; 315(1-2):19-26. DOI: 10.1016/j.mce.2009.09.008. View

5.
Bhavani N . Transient congenital hypothyroidism. Indian J Endocrinol Metab. 2011; 15(Suppl 2):S117-20. PMC: 3169860. DOI: 10.4103/2230-8210.83345. View